Related Experiment Videos
Human beta-tryptase is a ring-like tetramer with active sites facing a central pore
P J Pereira1, A Bergner, S Macedo-Ribeiro
1Abteilung für Strukturforschung, Max-Planck-Institut für Biochemie, Martinsried, Germany.
Nature
|April 1, 1998
Summary
Human beta-tryptase functions as a heparin-stabilized tetramer, explaining its unique properties and resistance to inhibitors. This structure, revealed by X-ray crystallography, is key for developing new tryptase inhibitors.
Area of Science:
- Biochemistry
- Structural Biology
- Enzymology
Background:
- Human beta-tryptase is a mast-cell-specific serine proteinase implicated in allergic and inflammatory conditions.
- Tryptase exhibits unique biochemical properties, including activity dependence on heparin stabilization and resistance to endogenous inhibitors.
Purpose of the Study:
- To elucidate the unique tetrameric structure of human beta-tryptase.
- To understand how this structure contributes to tryptase's biochemical characteristics.
- To provide a foundation for designing novel tryptase inhibitors.
Main Methods:
- X-ray crystallography was used to determine the 3-A crystal structure of human beta-tryptase.
- The structure was analyzed in a complex with 4-amidinophenyl pyruvic acid.
- Structural features, including monomer interactions and active site accessibility, were examined.
Main Results:
- Human beta-tryptase forms a stable tetramer with pseudo 222 symmetry, characterized by a square flat ring arrangement of four monomers.
- Unique loop segments around the active site mediate inter-monomer contacts, differing significantly from other trypsin-like proteinases.
- The tetrameric structure creates a central pore, limiting access for large substrates and inhibitors.
- Heparin likely stabilizes the tetramer through interactions with a positively charged surface spanning adjacent monomers.
Conclusions:
- The unique tetrameric architecture of human beta-tryptase explains its enzymatic activity, heparin dependence, and inhibitor resistance.
- Understanding this structure is crucial for the rational design of specific and effective tryptase inhibitors for therapeutic applications.